BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

16154

0

REMUS

img img img img
No Data Available

Remus Pharmaceuticals performance

Today’s low

Today’s high

₹ 713.50 ₹ 715.00
₹ 715.00

52 week low

52 week high

₹ 611.05 ₹ 1288.50
₹ 715.00

Open Price

₹ 715.00

Prev. Close

₹ 733.95

Volume (Shares)

300.00

Total traded value

₹ 2.14

Upper Circuit

₹ 880.70

Lower Circuit

₹ 587.20

info

Remus Pharmaceuticals Share Price Update

As of the latest trading session, Remus Pharmaceuticals share price is currently at ₹ 713.5, which is down by ₹ -20.45 from its previous closing. Today, the stock has fluctuated between ₹ 713.50 and ₹ 715.00. Over the past year, Remus Pharmaceuticals has achieved a return of -39.16 %. In the last month alone, the return has been 3.27 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Remus Pharmaceuticals fundamentals


  • Market cap (Cr)

    842.60

  • P/E Ratio (TTM)

    43.45

  • Beta

    0.87

  • Book Value / share

    205.55

  • Return on equity

    10.06%

  • EPS (TTM)

    16.76

  • Dividend yield

    0.20%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text
  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    0.20%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text

Remus Pharmaceuticals Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 79.16
Operating Expense 55.43
Net Profit 19.90
Net Profit Margin (%) 25.13
Earnings Per Share (EPS) 33.75
EBITDA 28.89
Effective Tax Rate (%) 25.30
Particulars MAR 2024 (Values in Cr)
Revenue 63.94
Operating Expense 44.40
Net Profit 16.62
Net Profit Margin (%) 25.99
Earnings Per Share (EPS) 29.40
EBITDA 23.81
Effective Tax Rate (%) 25.63
Particulars MAR 2023 (Values in Cr)
Revenue 45.03
Operating Expense 35.19
Net Profit 8.50
Net Profit Margin (%) 18.87
Earnings Per Share (EPS) 83.24
EBITDA 12.12
Effective Tax Rate (%) 25.50
Particulars MAR 2022 (Values in Cr)
Revenue 24.72
Operating Expense 20.83
Net Profit 3.43
Net Profit Margin (%) 13.87
Earnings Per Share (EPS) 34.34
EBITDA 4.85
Effective Tax Rate (%) 25.59
Particulars MAR 2025 (Values in Cr)
Book Value / Share 434.40
ROE % 18.58
ROCE % 21.60
Total Debt to Total Equity 0.09
EBITDA Margin 8.17
Particulars MAR 2024 (Values in Cr)
Book Value / Share 1072.72
ROE % 15.40
ROCE % 17.79
Total Debt to Total Equity 0.09
EBITDA Margin 14.93
Particulars MAR 2025 (Values in Cr)
Book Value / Share 411.24
ROE % 10.06
ROCE % 13.33
Total Debt to Total Equity 0.02
EBITDA Margin 36.50
Particulars MAR 2024 (Values in Cr)
Book Value / Share 1044.56
ROE % 19.25
ROCE % 24.46
Total Debt to Total Equity 0.07
EBITDA Margin 37.24
Particulars MAR 2023 (Values in Cr)
Book Value / Share 176.36
ROE % 66.10
ROCE % 68.21
Total Debt to Total Equity 0.32
EBITDA Margin 26.92
Particulars MAR 2022 (Values in Cr)
Book Value / Share 65.78
ROE % 70.58
ROCE % 92.25
Total Debt to Total Equity 0.05
EBITDA Margin 19.66
Particulars MAR 2021 (Values in Cr)
Book Value / Share 3143.70
ROE % 41.09
ROCE % 48.98
Total Debt to Total Equity 0.12
EBITDA Margin 8.74
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 8.14
Total Assets 432.64
Total Liabilities 432.64
Total Equity 282.55
Share Outstanding 5892000
Price to Book Ratio 5.44
Return on Assets (%) 6.71
Return on Capital (%) 9.58
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.85
Total Assets 333.11
Total Liabilities 333.11
Total Equity 175.21
Share Outstanding 1473000
Price to Book Ratio 6.61
Return on Assets (%) 6.16
Return on Capital (%) 10.99
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 4.37
Total Assets 280.31
Total Liabilities 280.31
Total Equity 242.22
Share Outstanding 5892000
Price to Book Ratio 5.44
Return on Assets (%) 7.09
Return on Capital (%) 8.14
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 10.84
Total Assets 183.49
Total Liabilities 183.49
Total Equity 153.55
Share Outstanding 1473000
Price to Book Ratio 6.61
Return on Assets (%) 9.05
Return on Capital (%) 10.72
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.03
Total Assets 34.66
Total Liabilities 34.66
Total Equity 19.13
Share Outstanding 1085000
Price to Book Ratio 0.00
Return on Assets (%) 24.53
Return on Capital (%) 31.4
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.14
Total Assets 15.86
Total Liabilities 15.86
Total Equity 6.57
Share Outstanding 1000000
Price to Book Ratio 0.00
Return on Assets (%) 21.65
Return on Capital (%) 50.73
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.83
Total Assets 11.01
Total Liabilities 11.01
Total Equity 3.14
Share Outstanding 10000
Price to Book Ratio 0.00
Return on Assets (%) 9.61
Return on Capital (%) 30.96
Particulars MAR 2025 (Values in Cr)
Net Income 47.34
Cash from Operations 14.46
Cash from Investing -10.55
Cash from Financing 6.07
Net change in Cash 2.51
Free Cash Flow 18.44
Particulars MAR 2024 (Values in Cr)
Net Income 30.17
Cash from Operations 7.16
Cash from Investing -30.11
Cash from Financing 27.67
Net change in Cash -1.09
Free Cash Flow 10.45
Particulars MAR 2025 (Values in Cr)
Net Income 26.64
Cash from Operations 23.11
Cash from Investing -12.42
Cash from Financing -1.42
Net change in Cash 1.75
Free Cash Flow 27.06
Particulars MAR 2024 (Values in Cr)
Net Income 22.35
Cash from Operations 12.56
Cash from Investing -47.24
Cash from Financing 41.63
Net change in Cash 0.70
Free Cash Flow 16.15
Particulars MAR 2023 (Values in Cr)
Net Income 11.41
Cash from Operations 8.31
Cash from Investing -15.19
Cash from Financing 11.76
Net change in Cash 1.88
Free Cash Flow 11.04
Particulars MAR 2022 (Values in Cr)
Net Income 4.61
Cash from Operations 6.23
Cash from Investing -4.54
Cash from Financing -0.17
Net change in Cash 0.31
Free Cash Flow 6.30
Particulars MAR 2021 (Values in Cr)
Net Income 1.40
Cash from Operations 0.24
Cash from Investing -0.13
Cash from Financing -0.11
Net change in Cash -0.36
Free Cash Flow 0.31
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 29.09 14.26 1.51 222.93 25.97 / 64.99
BLISS GVS PHARMA LTD 142.75 13.78 1.33 1510.14 105.05 / 190.65
CIPLA LTD 1507.25 22.38 3.69 121751.32 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 351.15 9.23 2.64 1033.47 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 29.09 23.65 4.05 222.93 25.97 / 64.99
AMRUTAJAN HEALTH LTD 671.80 34.26 5.67 1942.22 548.05 / 829.00
ASTRAZENECA PHARMA IND LT 9124.55 98.68 28.54 22811.38 6301.00 / 10653.05
BLISS GVS PHARMA LTD 142.75 19.26 1.36 1510.14 105.05 / 190.65

Remus Pharmaceuticals shareholding pattern

Holding

24.07%
70.9%
5.01%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

Remus Pharmaceuticals Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
715.00 -2.58 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 729.60
  • 26 Days 711.10
  • 10 Days 714.80
  • 50 Days 728.90
  • 12 Days 712.00
  • 100 Days 782.20
  • 20 Days 709.40
  • 200 Days 859.70
750.22 PIVOT

First Support

742.43

First Resistance

763.43

Second Support

729.22

Second Resistance

771.22

Third Support

721.43

Third Resistance

784.43

RSI

59.53

ADX

30.67

MACD

-1.18

Williams % R

-2.20

Commodity Channel Index (CCI)

144.60

Date

2025-12-15

Week

4467.00

Same Day

2100.00

Month

2924.00

1 Year

0.86

3 Year

0.97

Over 1 Month

3.27%

down

Over 1 Year

-39.16%

down

Over 3 Months

-7.84%

down

Over 3 Years

49.84%

down

Over 6 Months

-19.43%

down

Over 5 Years

0.00%

down

Remus Pharmaceuticals Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
14 Nov 2025 0.5 Interim 1 14 Nov 2025 Equity shares
18 Sep 2025 0.5 Final 18 Sep 2025 Equity shares
19 Nov 2024 1.0 Interim 20 Nov 2024 Equity shares
02 May 2024 4.0 Interim 2 02 May 2024 Equity shares
27 Oct 2023 2.0 Interim 28 Oct 2023 Equity shares
15 Sep 2023 2.0 Final 15 Sep 2023 Equity shares
Ex-Date Ex-Bonus Ratio
04 Jul 2025 04 Jul 2025 1:1
06 Jun 2024 06 Jun 2024 3:1
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Remus Pharmaceuticals Ltd?

Answer Field

Remus Pharmaceuticals Ltd share price is for NSE ₹ 713.50 & for BSE ₹ 0.00 as on Dec 17 2025 12:17 PM.

What is the Market Cap of Remus Pharmaceuticals Ltd Share?

Answer Field

The market cap of Remus Pharmaceuticals Ltd for NSE ₹ 420.39 & for BSE ₹ 0.00 as on Dec 17 2025 12:17 PM.

What is the 52 Week High and Low of Remus Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Remus Pharmaceuticals Ltd for NSE is ₹ 1,288.50 and ₹ 611.05 and for BSE is ₹ 0.00 and ₹ 0.00.

What is 1 year return for Remus Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -40.91%.

What is the P/E Ratio of Remus Pharmaceuticals Ltd Share?

Answer Field

As on Dec 17 2025 12:17 PM the price-to-earnings (PE) ratio for Remus Pharmaceuticals Ltd share is 43.45.

What is the PB ratio of Remus Pharmaceuticals Ltd Share?

Answer Field

As on Dec 17 2025 12:17 PM, the price-to-book (PB) ratio for Remus Pharmaceuticals Ltd share is 205.55.

How to Buy Remus Pharmaceuticals Ltd Share?

Answer Field

You can trade in Remus Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Remus Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Remus Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Remus Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59